IL-18 biology in severe asthma
2024

IL-18 Biology in Severe Asthma

publication Evidence: high

Author Information

Author(s): Thawanaphong Sarita, Nair Aswathi, Volfson Emily, Nair Parameswaran, Mukherjee Manali

Primary Institution: McMaster University

Hypothesis

This review aims to provide an overview of the current understanding of IL-18 biology and its role in severe asthma.

Conclusion

IL-18 is a key component in the pathophysiology of severe asthma, influencing both T2 and non-T2 inflammation.

Supporting Evidence

  • IL-18 contributes to chronic airway inflammation and hyperresponsiveness in severe asthma.
  • Emerging evidence highlights IL-18 as a critical player in both T2 and non-T2 inflammation.
  • IL-18's involvement in autoimmunity suggests it may be a target for new asthma therapies.

Takeaway

IL-18 is a special protein that helps control asthma, especially in severe cases, and scientists are looking at it as a new target for treatments.

Methodology

This is a review article synthesizing recent advancements and ongoing research on IL-18 and its role in asthma.

Limitations

The review does not provide original experimental data but synthesizes existing literature.

Digital Object Identifier (DOI)

10.3389/fmed.2024.1486780

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication